|Last Price||Today's Change||52-Week Range||Trading Volume|
|53.72||0.24 (+0.45%)||45.69 - 63.62||6.1 million (Below Avg)|
Market data as of 4:00PM 11/25/15. Quotes are delayed by at least 15 min.
Merck Announces Increased Quarterly Dividend
11/24/2015 12:35 PM ET
Merck Announces Initial Results for KEYTRUDA® (pembrolizumab) with Novel Immunotherapy Combinations from Three Investigational Studies Presented at the Society for Melanoma Research International Congress
11/21/2015 4:30 PM ET